Show simple item record

dc.contributor.authorKitchen, P
dc.contributor.authorLee, KY
dc.contributor.authorClark, D
dc.contributor.authorLau, N
dc.contributor.authorLertsuwan, J
dc.contributor.authorSawasdichai, A
dc.contributor.authorSatayavivad, J
dc.contributor.authorOltean, S
dc.contributor.authorAfford, S
dc.contributor.authorGaston, K
dc.contributor.authorJayaraman, P-S
dc.date.accessioned2020-01-02T11:21:46Z
dc.date.issued2019-12-16
dc.description.abstractAberrant Notch and Wnt signalling are known drivers of cholangiocarcinoma (CCA) but the underlying factors that initiate and maintain these pathways are not known. Here we show that the PRH/HHEX transcription factor forms a positive transcriptional feedback loop with Notch3 that is critical in CCA. PRH/HHEX expression was elevated in CCA and depletion of PRH reduced CCA tumour growth in a xenograft model. Overexpression of PRH in primary human biliary epithelial cells was sufficient to increase cell proliferation and produce an invasive phenotype. Interrogation of the gene networks regulated by PRH and Notch3 revealed that unlike Notch3, PRH directly activated canonical Wnt signalling. These data indicate that hyperactivation of Notch and Wnt signalling is independent of the underlying mutational landscape and has a common origin in dysregulation of PRH. Moreover, they suggest new therapeutic options based on the dependence of specific Wnt, Notch, and CDK4/6 inhibitors on PRH activity.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipThailand Research Fund (TRF)en_GB
dc.identifier.citationPublished online 16 December 2019en_GB
dc.identifier.doi10.1158/0008-5472.CAN-19-0942
dc.identifier.grantnumberMR/N012615/1en_GB
dc.identifier.grantnumberDBG5980005en_GB
dc.identifier.other0008-5472.CAN-19-0942
dc.identifier.urihttp://hdl.handle.net/10871/40208
dc.language.isoenen_GB
dc.publisherAmerican Association for Cancer Researchen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/31843982en_GB
dc.rights.embargoreasonUnder embargo until 16 December 2020 in compliance with publisher policyen_GB
dc.rights© 2019, American Association for Cancer Researchen_GB
dc.subjectcholangiocarcinomaen_GB
dc.subjectbile ducten_GB
dc.subjectbiliary epithelial cellsen_GB
dc.subjectcholangiocyteen_GB
dc.subjectHHEXen_GB
dc.subjectPRHen_GB
dc.subjectNotchen_GB
dc.subjectWnten_GB
dc.subjectepithelial-mesenchymal transitionen_GB
dc.titleA runaway PRH/HHEX-Notch3 positive feedback loop drives cholangiocarcinoma and determines response to CDK4/6 inhibitionen_GB
dc.typeArticleen_GB
dc.date.available2020-01-02T11:21:46Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Association for Cancer Research via the DOI in this recorden_GB
dc.identifier.journalCancer Researchen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2019-12-10
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-12-16
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-01-02T11:19:23Z
refterms.versionFCDAM
refterms.dateFOA2020-01-02T11:21:55Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record